Solta Medical Inc

Solta Medical — Thermage — Merger or Acquisition (July 2008)

19 slides from Solta Medical's merger presentation, Jul 7, 2008

  1. Slide 1: Creating a Global Leader in Aesthetic Devices

    Webcast Presentation Webcast Presentation July 7, 2008 July 7, 2008 Creating a Global Leader in Creating a Global Leader in Aesthetic Devices Aesthetic Devices

  2. Slide 2: Filed by Thermage, Inc. Pursuant to Rule 425

    Filed by Thermage, Inc. Pursuant to Rule 425 Under the Securities Act of 1933 and Pursuant to Rule 14a-12 Under the Securities Exchange Act of 1934 Subject Company: Thermage, Inc. Commission File No.: 001-33123

  3. Slide 3: Additional Information and Where You Can Find It

    Additional Information and Where You Can Find It This communication may be deemed to be solicitation material in respect of the proposed transaction between Thermage and Reliant. In connection with the transaction, Thermage will file a registration statement on Form S-4 with the SEC containing a pro

  4. Slide 4: Forward Looking Statements

    Forward Looking Statements Forward Looking Statements This presentation contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, including statements regarding potential transaction timing, projected financial results, and anticipated cost

  5. Slide 5: Creating a Global Leader: Strategic and Financial Rationale

    Strategic Rationale Financial Rationale Creating a Global Leader Creating a Global Leader Combines two of the most differentiated and valued brands in aesthetic devices Highly complementary product offering Targeting the highest growth market sectors Strong economies of scale Significant cross-selli

  6. Slide 6: Significant Synergy Opportunity

    Significant Synergy Opportunity Significant Synergy Opportunity EPS Accretive in 2009* Over $14 million in projected annual costs savings achieved in 12 months Significant efficiencies created in SG&A and manufacturing Leverage combined purchasing power Consolidate administrative activities and clos

  7. Slide 7: Combining Two of the Most Differentiated & Valued Brands in Aesthetic Devices

    Thermage Reliant NewCo Combining Two of the Most Differentiated Combining Two of the Most Differentiated & Valued Brands in Aesthetic Devices & Valued Brands in Aesthetic Devices Leader in skin tightening Recent introduction of cellulite reduction Over 500,000 procedures performed since commercializ

  8. Slide 8: Targeting the Highest Growth Markets

    CAGR for U.S. Procedures & Device Sales (2007-2011) Targeting the Highest Growth Markets Targeting the Highest Growth Markets 33% 14% 26% 11% 23% 16% 19% 34% 17% 11% 18% 12% 0% 5% 10% 15% 20% 25% 30% 35% 40% Skin Tightening Skin Rejuvenation Skin Resurfacing Cellulite Reduction Hair Removal Acne Red

  9. Slide 9: Cross Selling Opportunities

    Cross-Branding Opportunities Strong Combination Therapy One Stop Shopping For Physicians Potential to Bundle Technology Installed Base Over 1,500 Installed Base Over 2,500 Cross Selling Opportunities Cross Selling Opportunities

  10. Slide 10: Creating One of the Largest Sales Forces in Aesthetic Devices

    Largest Bifurcated U.S. Sales Force Focused on Disposables Focused on Generators Creating One of the Largest Sales Creating One of the Largest Sales Forces in Aesthetic Devices Forces in Aesthetic Devices

  11. Slide 11: 2007 Consumable Revenue Per Installed Instrument

    2007 Consumable Revenue Per Installed Instrument Consumable Revenue Consumable Revenue Dedicated sales force focused on consumables Proven cooperative marketing campaigns with physicians Enhanced resources to increase visibility with physicians and patients $20,300 $13,700 $- $5,000 $10,000 $15,000

  12. Slide 12: Creating a Strong Sustainable Business: 2007 Revenue Streams

    2007 Revenue Streams 68% 26% 20% 72% 42% 51% Creating a Strong Sustainable Business Creating a Strong Sustainable Business 6% 8% 7% 0% 20% 40% 60% 80% 100% Thermage Reliant NewCo Tips Systems Other

  13. Slide 13: Track Record of Innovation

    4/26/06 10/26/06 2/1/07 2/2/07 6/26/07 8/2/07 10/1/07 2/1/08 8/14/06 2/2/07 2/2/07 6/4/07 9/7/07 1/31/08 Q1 2007 Q4 Q3 Q4 Q3 Q2 Q1 Q2 Q1 2008 2006 Q1 2007 Q4 Q3 Q4 Q3 Q2 Q1 Q2 Q1 2008 2006 Eyes by Thermage™ Track Record of Innovation Track Record of Innovation ThermaCool®NXT Tummy by Thermage™ Hands

  14. Slide 14: Financial Overview

    Financial Overview Financial Overview Jack Glenn Chief Financial Officer

  15. Slide 15: Transaction Overview

    Purchase Consideration Pro Forma Ownership (treasury stock method) Board/Management Approvals Anticipated Timing To Closing Transaction Overview Transaction Overview 23.6 million shares and $25 million in cash, plus the assumption of $7.0 million of net debt, for an approximate total consideration o

  16. Slide 16: Combined Financial Strength

    Combined Financial Strength Combined Financial Strength Thermage Revenue $63.1 Reliant Revenue $70.5 Combined Company Revenue $133.6 Shares Outstanding 48 mil.

  17. Slide 17: International Sales

    International Sales International Sales 62% 38% United States Rest of World 52% 22% 16% 10% United States Asia Pacific Europe & Middle East Rest of World • Expansion of international distribution for Reliant products • Greater leverage with distributors

  18. Slide 18: Creating Strong Economies of Scale

    Strong Economies of Scale 2007 Revenue $63 $71 $102 $124 $124 $134 $141 $149 $0 $20 $40 $60 $80 $100 $120 $140 $160 THRM Reliant CUTR PMTI CYNO NewCo ELOS CLZR Creating Strong Economies of Scale Creating Strong Economies of Scale Source: Wall Street Research, and company (Thermage and Reliant) manag

  19. Slide 19: Creating a Global Leader: Strategic and Financial Rationale

    Strategic Rationale Financial Rationale Creating a Global Leader Creating a Global Leader Combines two of the most differentiated and valued brands in Aesthetics Highly complementary product offering Targeting the highest growth market sectors Strong economies of scale Significant cross-selling oppo

Thermage — Merger or Acquisition (July 2008) on 6ix